Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Retained Earnings: 2009-2024

Historic Retained Earnings for Fresenius Medical Care AG (FMS) over the last 17 years, with Sep 2025 value amounting to $13.8 billion.

  • Fresenius Medical Care AG's Retained Earnings rose 13.69% to $13.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 billion, marking a year-over-year increase of 13.69%. This contributed to the annual value of $12.0 billion for FY2024, which is 1.90% up from last year.
  • As of Q3 2025, Fresenius Medical Care AG's Retained Earnings stood at $13.8 billion, which was up 8.32% from $12.8 billion recorded in Q2 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Retained Earnings peaked at $13.8 billion during Q3 2025, and registered a low of $10.6 billion during Q3 2022.
  • For the 3-year period, Fresenius Medical Care AG's Retained Earnings averaged around $12.1 billion, with its median value being $12.0 billion (2024).
  • As far as peak fluctuations go, Fresenius Medical Care AG's Retained Earnings grew by 17.89% in 2021, and later decreased by 15.22% in 2022.
  • MRQ analysis of 5 years shows Fresenius Medical Care AG's Retained Earnings stood at $12.4 billion in 2021, then fell by 11.76% to $10.9 billion in 2022, then grew by 7.53% to $11.8 billion in 2023, then increased by 2.45% to $12.0 billion in 2024, then increased by 15.02% to $13.8 billion in 2025.
  • Its Retained Earnings was $13.8 billion in Q3 2025, compared to $12.8 billion in Q2 2025 and $12.1 billion in Q1 2025.